Scientific article
Open access

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Published inNature Communications, vol. 10, no. 1, 1486
Publication date2019

Immunogenic cell death (ICD) converts dying cancer cells into a therapeutic vaccine and stimulates antitumor immune responses. Here we unravel the results of an unbiased screen identifying high-dose (10 µM) crizotinib as an ICD-inducing tyrosine kinase inhibitor that has exceptional antineoplastic activity when combined with non-ICD inducing chemotherapeutics like cisplatin. The combination of cisplatin and high-dose crizotinib induces ICD in non-small cell lung carcinoma (NSCLC) cells and effectively controls the growth of distinct (transplantable, carcinogen- or oncogene induced) orthotopic NSCLC models. These anticancer effects are linked to increased T lymphocyte infiltration and are abolished by T cell depletion or interferon-γ neutralization. Crizotinib plus cisplatin leads to an increase in the expression of PD-1 and PD-L1 in tumors, coupled to a strong sensitization of NSCLC to immunotherapy with PD-1 antibodies. Hence, a sequential combination treatment consisting in conventional chemotherapy together with crizotinib, followed by immune checkpoint blockade may be active against NSCLC.

  • Animals
  • Antineoplastic Agents/administration & dosage
  • B7-H1 Antigen/genetics/immunology
  • Carcinoma
  • Non-Small-Cell Lung/drug therapy/genetics/immunology/physiopathology
  • Cell Death/drug effects
  • Cell Line
  • Tumor
  • Crizotinib/administration & dosage
  • Female
  • Humans
  • Interferon-gamma/immunology
  • Lung Neoplasms/drug therapy/genetics/immunology/physiopathology
  • Mice
  • Mice
  • Inbred C57BL
  • Programmed Cell Death 1 Receptor/genetics/immunology
  • T-Lymphocytes/immunology
Affiliation Not a UNIGE publication
Citation (ISO format)
LIU, Peng et al. Crizotinib-induced immunogenic cell death in non-small cell lung cancer. In: Nature Communications, 2019, vol. 10, n° 1, p. 1486. doi: 10.1038/s41467-019-09415-3
Main files (1)
Article (Published version)
ISSN of the journal2041-1723

Technical informations

Creation07/08/2021 5:17:00 PM
First validation07/08/2021 5:17:00 PM
Update time03/16/2023 1:06:03 AM
Status update03/16/2023 1:06:01 AM
Last indexation02/12/2024 12:08:59 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack